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Abstract
Background: For many years, African Dust Storms (ADE) has been thought to be associated with high prevalence
of asthma in Puerto Rico (PR). Endotoxins (ENX) have been associated with ADE particulate matter (PM) and are
known to promote pro-inflammatory responses in lung cells of susceptible individuals through the Toll-like receptor
(TLR2/4) signaling pathways. Genetic variants are plausible contributors to such susceptibility. Therefore, we have
evaluated a series of nine single nucleotide polymorphisms (SNPs) in TLR genes, which have been correlated
positive and negatively to asthma prevalence and/or risk, in the Puerto Rican asthmatic population.
Methods: The following SNPs were evaluated in 62 asthmatics and 61 controls through Taqman® Real Time
PCR Assay: TLR4 (+896A/G, +1196C/T, −6687A/G); TLR2 (+596C/T, −16934 T/A, +399A/G, +1349C/T) and CD14
(−159C/T, +1188C/G). Genotypes were assessed for asthma association employing an odds ratio (OR) analysis.
Results: Minor allele frequencies (n = 123) were determined for those variants as 0.07, 0.06, 0.35, 0.35, 0.37, 0.29,
0.04, 0.35 and 0.11, respectively. Two (+596C/T, +399A/G) TLR2 SNPs showed to be more represented in the
asthmatic group by 89 % and 65 %, respectively. TLR4 SNP +896A/G analysis revealed only 1 G/G genotype
(2 %) on the asthmatic group. The CD14 SNPs were similarly represented in the Puerto Rican population. Only
the TLR2 +596 SNP was found to be significantly associated to asthma (OR = 3.24 for CT, 2.71 for TT) and particularly
to females.
Conclusions: The identification of TLR SNPs will reveal potential candidates for gene-environment interactions in
Puerto Ricans. As far as we know this is the first study to evaluate this type of TLR gene polymorphisms in Puerto
Rican asthmatics, contributing to the current knowledge in the Hispanic population.
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Background
Asthma is an influential chronic illness in children and
youth in the United States (US) and worldwide. Over the
last decades it has been estimated that 300 million indi-
viduals are affected with asthma all over the world [1].
Asthma poses a heavy burden, which has steeply increased
in minorities, particularly in Puerto Rican children [2].
Puerto Ricans exhibit the highest asthma prevalence
(current: 16.6 % vs. 11.1 %/Non-Hispanic blacks, 8.2 %/
Non-Hispanic whites and 6.3 %/total Hispanics for 2009
in US) than any other racial or ethnic group [3–6]. Recent
statistics from the National Health Interview Survey
(NHIS), 2013 indicate that Puerto Ricans (18.8 %) had
the higher asthma prevalence in the US; particularly in
adult females (15.6 %). Not only in the island but also
in the US, Puerto Ricans have high asthma prevalence
[3] which suggests a genetic association. Ledogar et al.
[7] found that Puerto Ricans living in New York City
had asthma prevalence very similar to those living in
the island (~16-18 %), especially pediatric patients from
0–12 yrs of age.
The striking racial and ethnic disparities in asthma
prevalence cannot be solely attributed to one specific
factor but to the interaction among many factors including
genetic background, environmental exposures, nutrition,
as well as socioeconomic status and access to health care
[8, 9]. Indeed, genetic variation along with early-life envir-
onmental and lifestyle exposures correlated to admixture
influences (African ancestry) can affect lung development
and growth in Puerto Rican children [10]. A literature re-
view for 2000–2009 revealed a list of 127 genes and re-
spective proteins linked to asthma in which TLR pathway
intermediaries are influential members [11]. Puerto Ricans
are heavily exposed to PM airborne constituents such
as ENX in constant African Dust Storms (ADE) [12–14].
Endotoxins are known ligands to Toll-like receptors
(TLR2/4) and its co-receptor, the Cluster of Differenti-
ation 14 (CD14) [15, 16]. The possible modification of
ENX-receptor interaction and its link to specific single nu-
cleotide polymorphisms (SNPs) could play significant role
with asthma susceptibility [17]. Epidemiological studies
have evaluated numerous polymorphisms in TLR2, TLR4
and CD14 in relation to asthma and similar phenotypes
and some were significantly associated with high asthma
prevalence, risk or severity. Two SNPs in the CD14 gene
(−260C/T and -159C/T) have been shown to be associated
with asthma susceptibility in French, Dutch and English
populations [18–20]. The CD14 -159C/T variant was
found to be as frequent as 0.67 in Puerto Ricans [21].
The TLR2 +596C/T variant was related to lower asthma
risk in a French population [18]. Another group reports
-16934 T/A to link significantly to a less tendency to
have asthma diagnosis, symptoms and atopy between
others [22]. Other TLR2 SNPs have been associated
with allergic asthma [23] and TLR4 SNPs (Asp299Gly
and T399I) with asthma pathogenesis in a German
population [24]. Interestingly, the Asp299Gly SNP was
found to be associated with 4-fold higher asthma preva-
lence and 7-fold higher prevalence of atopic asthma in
a Swedish children population [25]. However, these find-
ings have not been consistent in all studies [26]. Raby
et al. [27] found no association of six different TLR4 SNPs
and asthma susceptibility in three different ethnic groups
from US and Canada. Furthermore, Nishimura et al. [28]
observed no association between CD14 -159C/T SNP and
asthma in a Japanese population. The variability in the as-
sociation of the aforementioned SNPs to asthma outcomes
may be attributed to inherent factors that are different
among the populations studied and it has been suggested
that gene-environment interactions may also explain the
variable association [26, 29]. Choudry et al. [21] found as-
sociation of the CD14 + 1437C/G SNP and asthma sever-
ity in Mexican and Puerto Rican asthmatics exposed to
Environmental Tobacco Smoke, ETS and suggested a
gene-environment interaction between ETS and that gene
variant together with the -159C/T SNP. Exposure of
Puerto Rican individuals with those variants showed a sig-
nificant reduction in pulmonary function and immuno-
globulin E (IgE) levels [21].
There has been no study performed on the Puerto
Rican asthmatic population living in the island with par-
ticular interest in the frequency of polymorphisms in the
TLR2/4 genes. This study evaluates specific SNPs in TLR2
(4 variants), TLR4 (3 variants) and CD14 (2 variants) genes
in a Puerto Rican asthmatic population. The SNP selection
was based on literature findings and their functionality in
terms of significant associations to the condition of asthma.
Methods
Case–control study
Sixty-two Puerto Rican asthmatics 14 years old or more
born from Puerto Rican parents and residents of Puerto
Rico were recruited for the study. These subjects were
diagnosed with asthma by a physician. The control group
was represented by sixty-one Puerto Rican subjects with-
out asthma, rhinosinusitis or any other chronic allergic
and/or pro-inflammatory condition, including Chronic
Obstructive Pulmonary Disease (COPD). A questionnaire
containing personal, lifestyle, health, asthma family his-
tory, African Dust awareness and knowledge (perception)
was completed by all subjects for descriptive and analytical
purposes. Information about atopic status of subjects was
not considered. Experimental and control subjects were
recruited from the University of Puerto Rico, School of
Medicine Clinics. Eligibility of all subjects was evaluated ap-
plying the inclusion/exclusion criteria established. Selected
candidates were asked to sign an informed consent docu-
ment, interviewed and asked to provide a saliva sample. The
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experimental design protocol (#A8570111) used in this study
was reviewed and approved by the University of Puerto Rico
– Medical Sciences Campus Institutional Review Board
(UPR MSC IRB).
DNA extraction and genotyping
Saliva samples were obtained from subjects using Saliva
Collection Kits (SalivaGene® from B-Bridge International,
Inc.). Genomic DNA extractions from these samples were
performed following the manufacturer instructions. Ex-
tracted DNA was then diluted to 7 ng/μl and used for
SNP genotyping assays through Real-Time Polymerase
Chain Reaction (PCR) and Taqman® probes (Applied Bio-
systems) following the corresponding recommendations
from the manufacturer. A total of 9 SNPs from three
genes were analyzed. These were the TLR4 gene: +896A/G
(rs4986790), +1196C/T (rs4986791) and -6687G/A
(rs2737190); the TLR2 gene: +596C/T (rs3804099),
−16934 T/A (rs4696480), +399A/G (rs13150331) and
+1349 T/C (rs3804100); and in the CD14 gene: −159G/A
(rs2569190), +1188C/G (rs4914).
Statistical analyses
Three major parameters were used for sample size calcu-
lation: asthma prevalence (12.5-13 %, Continuous Health
Survey for the Municipalities of Puerto Rico, 2003), the
study site scenario of 696 patients (derived from 13–16
patients per week, where half or a third are asthmatics)
and a confidence interval of 95 %. The Epi-Info 6.04d
software was used as an instrument for that estimation,
providing an approximate population size of 60 cases
and 60 controls. Descriptive statistics (means, frequen-
cies and standard deviations) were used to describe the
studied population. Differences in the distribution of
socio-demographic characteristics between asthmatics
and controls were also evaluated. Multivariate analysis
was performed to compare the following variables: 1)
having asthma or not and 2) the presence or absence of
one of the polymorphisms previously stated. Differences
in proportions between groups were assessed by Pearson
chi-square distribution, t test or Fisher’s exact test as ap-
propriate. The magnitude of these associations was deter-
mined estimating prevalence odds ratio (OR) along with
95 % confidence intervals (CI) and p values for signifi-
cance using a simple logistic regression model. Significant
associations were adjusted by the potential confounding
interaction variable of gender. Interaction terms formed
by all combination pairs of the predictor variables within
the multivariate model were tested with the likelihood
ratio test. Data analysis was performed using the Data
Analysis and Statistical Software STATA® 11.
Minor allele frequency (MAF) was calculated for each
SNP in the experimental and control groups using the
following equation: (N minor allele)/(total N × 2). Hardy-
Weinberg equilibrium was tested through the X2
goodness-of-fit test to compare the observed SNP
genotype frequencies with the expected ones. The On-
line Encyclopedia for Genetic Epidemiology Studies
(OEGE) 2006-2011© Hardy Weinberg calculator tool
(www.oege.org/software/hardy-weinberg.html) was used
to perform this test [30].
Results
Descriptive profiles
Sixty-two Puerto Rican asthmatics and sixty-one non-
asthmatic control subjects were recruited for this case–
control study. Table 1 illustrates the characteristic profiles
for both study groups. The mean age for the asthmatic
group was 41.2 ± 13.5 years and 46 ± 16.4 for the control.
This particular characteristic was the only one that exhib-
ited a statistically significant difference between the pro-
portions of asthmatics and controls (p 0.035). Eighteen
percent of the asthmatics were males while 82 % were fe-
males. In the controls, 34 % were males while 66 % were
females. Most of the population studied lived in the
metropolitan area, 64 % of asthmatics and 56 % controls.
In terms of smoking habits, 31 % of the asthmatics and
23 % of the controls have smoke; and 83 % of the experi-
mental group and 62 % of the control group were current
smokers. A 54 % (asthmatics) vs. 51 % (controls) reported
to have pets in their homes. Eighty-six percent of the asth-
matics stated to have family history of asthma (first line
relatives: parents and brothers/sisters) as compared to
81 % of the controls. A 48 % of the asthmatics reported to
have experienced asthma exacerbations and the majority
of them suffered the effects frequently. Eighty-nine
percent of the asthmatics reported the use of asthma
prescribed medications.
As part of exposure to environmental events, the sub-
jects were asked some questions about African Dust
knowledge and perception. Almost all the subjects knew
what the African Dust was: 95 % of the asthmatics and
98 % of the controls. Only, 47 % of the asthmatics expe-
rienced an adverse effect caused by the dust.
SNP genotyping
Three TLR4, 4 TLR2 and 2 CD14 gene polymorphisms
were evaluated in this study. The distribution of each
SNP among asthmatics and controls is presented in
Tables 2, 3 and 4. All gene variants were in Hardy
Weinberg equilibrium as indicated by chi-square values at
p-values >0.05 shown on Tables 2, 3 and 4.
TLR4 +896 AA and AG genotypes were similar be-
tween the groups and only 1 homozygote GG was ob-
served in the asthmatics. Minor allele frequencies
were practically the same (Table 2). In the case of
TLR4 +1196, the distribution of genotypes and MAF
was similar in both groups. The TLR4 -6687 presented
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more AG genotypes in asthmatics, but more AA in
controls. Minor allele frequency (G) was somewhat higher
in asthmatics (37 % vs. 33 %).
TLR2 gene variant +596 showed more heterozygotes CT
(58 %), more homozygotes TT (31 %) and less homozygotes
CC (11 %) in asthmatics compared to controls (Table 3).
Minor allele (C) was equally distributed in asthmatics and
controls. Other 2 TLR2 variants, −16934 and +1349 re-
vealed more heterozygotes in the asthmatic group, although
more CC and AA homozygotes, respectively in the control
group. The +1349 SNP showed only 1 CC homozygote in
controls. Lastly, the +399 SNP presented more AG and less
AA in asthmatics than among controls and the same GG in
both groups. Minor allele frequency (G) was higher among
asthmatics (32 % vs. 26 %).
The CD14 polymorphism, −159 was characterized by
more AG genotypes in the control group and more AA
genotypes in the asthmatic group (Table 4). The minor
Table 2 TLR4 SNP Genotypes and Minor Allele Frequencies (MAF) along with Hardy Weinberg Equilibrium Values in Asthmatic and
Control Groups
SNP Genotypes Asthmatics N (%) Controls N (%) Total N (%) Hardy Weinberg Equilibrium (X2, p > 0.05)
TLR4 +896 0.11
AA 54 (87.1) 51 (83.6) 105 (85.4)
AG 7 (11.3) 10 (16.4) 17 (13.8)
GG 1 (1.6) 0 1 (0.8)
MAF (G) 0.06 (6) 0.08 (8)
TLR4 +1196 0.52
CC 55 (88.7) 53 (86.9) 108 (87.8)
CT 7 (11.3) 8 (13.1) 15 (12.2)
MAF (T) 0.06 (6) 0.07 (7)
TLR4 -6687 0.69
GG 10 (16.1) 11 (18.0) 21 (17.1)
AG 36 (58.1) 29 (47.5) 65 (52.2)
AA 16 (25.8) 21 (34.4) 37 (30.1)
MAF (G) 0.37 (37) 0.33 (33)
Hardy Weinberg equilibrium chi-square values were acquired under a p-value >0.05
Table 1 Characteristic profiles of asthmatic and control subjects
Characteristic [N (%) or otherwise stated] Puerto Ricana Asthmatic Group Puerto Rican Control Group
N = 62 N = 61
Age in years [Mean (SD)]d 41.2 (13.5) 46 (16.4)
Age by Category
14–24 5 (8.1) 3 (4.9)
25–35 20 (32.3) 20 (32.8)
36–45 13 (20.9) 5 (8.2)
46+ 24 (38.7) 33 (54.1)
Gender [N (%) Males/N (%) Females] 11 (17.7)/51 (82.3) 21 (34.4)/40 (65.6)
Residence in Metropolitan (Urban) Area 40 (64.5) 34 (55.7)
Smokingc 19 (30.6) 14 (22.9)
Indoor Pets 33 (54.1) 31 (50.8)
Family Asthma Historyb 49 (86) 34 (80.9)
Asthma Exacerbations 30 (48.4)
Asthma Medication Usage 55 (88.7)
African Dust Knowledge 59 (95.2) 60 (98.4)
Asthma symptoms caused by African Dust 29 (46.8)
Legend: aPuerto Rican ancestry (European, West African and Native American); bfirst line relatives: parents, sons (daughters) and/or brothers (sisters) have or had
asthma; SD means standard deviation and cthe smoking characteristic is based on the answer to the question, have you ever smoked in your life? dThe only
characteristic that showed a statistically significant difference between the proportions of asthmatics and controls was age with a p value of 0.035
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allele frequency (A) was the same in asthmatics and
non-asthmatic controls. CD14 +1188 SNP was repre-
sented with more CG genotypes and higher MAF (G) in
controls and more CC genotypes among asthmatics.
Logistic regression and interaction analyses
A logistic regression analysis was performed to assess the
association of each socio-demographic trait and having
the condition of asthma (Table 5). Gender, age, education,
marital status, residence, lifestyle (smoking and having
pets) and asthma history were considered in the analysis.
An OR of 2.43 resulted for the significant association of
gender, specifically in females with asthma (p 0.038). Fur-
thermore, asthma was associated to the age category of
36–45 years with an OR of 3.57 (p 0.031).
The analysis revealed a significant association between
the TLR2 +596 CT genotype and asthma in the Puerto
Rican population with an OR of 3.24, p 0.023 (Table 6).
Moreover, the TT genotype was marginally associated to
Table 3 TLR2 SNP Genotypes and Minor Allele Frequencies (MAF) along with Hardy Weinberg Equilibrium Values in Asthmatic and
Control Groups
SNP Genotypes Asthmatics N (%) Controls N (%) Total N (%) Hardy Weinberg Equilibrium (X2, p > 0.05)
TLR2 +596 0.14
CC 7 (11.3) 17 (27.9) 24 (19.5)
CT 36 (58.1) 27 (44.3) 63 (51.2)
TT 19 (30.6) 17 (27.8) 36 (29.3)
MAF (C) 0.35 (35) 0.36 (36)
TLR2 -16934 0.65
TT 17 (27.4) 14 (23.0) 31 (25.2)
AT 32 (51.6) 26 (42.6) 58 (47.2)
AA 13 (21.0) 21 (34 .4) 34 (27.6)
MAF (A) 0.35 (35) 0.38 (38)
TLR2 +399 0.88
AA 23 (37.1) 29 (47.5) 52 (42.3)
AG 33 (53.2) 26 (42.6) 59 (48.0)
GG 6 (9.7) 6 (9.8) 12 (9.7)
MAF (G) 0.32 (32) 0.26 (26)
TLR2 +1349 2.53
TT 56 (90.3) 57 (93.4) 113 (91.9)
CT 6 (9.7) 3 (4.9) 9 (7.3)
CC 0 1 (1.6) 1 (0.8)
MAF (C) 0.05 (5) 0.03 (3)
Hardy Weinberg equilibrium chi-square values were acquired under a p-value >0.05
Table 4 CD14 SNP Genotypes and Minor Allele Frequencies (MAF) along with Hardy Weinberg Equilibrium Values in Asthmatic and
Control Groups
SNP Genotypes Asthmatics N (%) Controls N (%) Total N (%) Hardy Weinberg Equilibrium (X2, p > 0.05)
CD14 -159 0.05
GG 20 (32.2) 19 (31.2) 39 (31.7)
AG 29 (46.8) 31 (50.8) 60 (48.8)
AA 13 (21.0) 11 (18.0) 24 (19.5)
MAF (A) 0.35 (35) 0.35 (35)
CD14 +1188 1.72
CC 51 (82.3) 46 (75.4) 97 (78.9)
CG 11 (17.7) 15 (24.6) 26 (21.4)
MAF (G) 0.26 (26) 0.12 (12)
Hardy Weinberg equilibrium chi-square values were acquired under a p-value >0.05
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asthma with an OR of 2.71 (p 0.074). There was no asso-
ciation of any other TLR pathway SNPs with asthma.
Analysis of the genotypes adjusted by gender also re-
sulted in significant associations of TLR2 +596 genotypes
and asthma in the Puerto Rican population (Table 7). Fe-
males with the CT genotype were strongly associated to
asthma with an OR of 6.53 (p 0.004). The TT genotype,
which was initially marginal in significance when using
the crude OR analysis was statistically significant after the
gender adjustment, where females exhibited an OR of 6.04
(p 0.008). Males with the CT genotype presented an OR of
0.67 but it was not significant (p 0.665). Another TLR2
SNP, −16934 turned to be significant in males with the AA
genotype (OR 0.13/ p 0.039).
The likelihood ratio test revealed interaction between
2 of the 9 SNPs and asthma, TLR2 +596 (X2 = 10.21,
Table 5 Logistic Regression Analysis for the association of each
socio-demographic trait and asthma. “Yes/No” categories were
based on the answer of having or not the respective trait.
Abbreviations: CI = confidence interval
Characteristics OR 95 % CI P-value
Gender
Male 1.00
Female 2.43 1.05-5.63 0.038
Age
14-24 2.29 0.50-10.53 0.286
25-35 1.37 0.61-3.10 0.443
36-45 3.57 1.12-11.38 0.031
46+ 1.00
Education
High School or less 2.00 0.67-5.99 0.216




Married/Living with someone 0.65 0.30-1.41 0.274
Widow 0.50 0.08-3.26 0.469
Divorced 0.64 0.09-2.20 0.481
Metropolitan Area Residence
No 1.00
Yes 1.44 0.70-2.98 0.321
Smoking Anytime in Life
No 1.00
Yes 1.48 0.66-3.32 0.337
Currently Smoking
No 1.00
Yes 3.13 0.59-16.58 0.181
Passive Smoking
No 1.00
Yes 1.50 0.50-4.52 0.471
First Line Asthmatic Relative
No 1.00
Yes 1.44 0.49-4.22 0.504
Indoor Pets
No 1.00
Yes 1.14 0.56-2.32 0.717
Legend: OR odds ratio, CI confidence interval
Table 6 Logistic Regression Analysis for the association of each
TLR4, TLR2 and CD14 SNPs and asthma
SNP Genotypes OR 95 % CI P-value
TLR4 +896
AA 1.00
AG 0.66 0.23-1.87 0.435
TLR4 +1196
CC 1.00
CT 0.84 0.29-2.49 0.757
TLR4 -6687
GG 1.00
AG 1.37 0.51-3.66 0.536
AA 0.84 0.29-2.46 0.748
TLR2 +596
CC 1.00
CT 3.24 1.18-8.91 0.023
TT 2.71 0.91-8.13 0.074
TLR2 -16934
TT 1.00
AT 1.01 0.42-2.43 0.976
AA 0.51 0.19-1.37 0.182
TLR2 +399
AA 1.00
AG 1.60 0.76-3.39 0.220
GG 1.26 0.36-4.43 0.718
TLR2 +1349
TT 1.00
CT 2.04 0.49-8.54 0.331
CD14 -159
GG 1.00
AG 0.89 0.49-2.00 0.774
AA 0.12 0.41-3.11 0.824
CD14 +1188
CC 1.00
CG 0.66 0.28-1.59 0.354
GG
Legend: OR odds ratio, CI confidence interval
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p 0.0061) and TLR2 + 399 (X2 = 7.84, p 0.0199). Others
did not present a significant interaction [TLR4 + 896
(X2 = 2.24, p 0.1348); TLR4 + 1196 (X2 = 2.77, p 0.0961);
TLR4 -6687 (X2 = 3.66, p 0.1607) and CD14 -159 (X2 =
1.02, p 0.5999)].
Discussion
The TLR2 +596 SNP (genotypes: CT and TT) was asso-
ciated to asthma within the Puerto Rican population as
demonstrated among French atopic subjects carrying the
allele C, while non-atopic subjects revealed a positive
but not significant association [18]. More importantly,
the authors discovered a gene-environment interaction,
where non-atopic subjects with the C allele were pro-
tected from asthma by means of living in a country en-
vironment. This variant was also studied in Korean
patients of allergic rhinitis where no significant differ-
ence was found compared to controls and no correlation
to total serum IgE levels, but it was associated to periph-
eral blood eosinophil counts [31]. Interestingly, MAFs
(C) found in that study (cases: 0.32; controls: 0.31) cor-
relate well with our findings in Puerto Rican asthmatics
in spite of notable differences in sample size (cases: 0.35;
controls: 0.36) [31, 32]. This polymorphism was associ-
ated to protection to non-atopic asthma in children
from the International Study of Asthma and Allergy in
Childhood (ISAAC) phase II [33]. A haplotype involving
TLR +596 C and TLR2 +1349 C was also not related to
allergic asthma in Norwegian asthmatic children [23].
The TLR2 +596 SNP was particularly associated to fe-
males after gender adjustments. The fact that this SNP
was significantly predominant in Puerto Rican asthmatic
females is consistent with a higher prevalence asthma re-
ported for females vs. males: 20.4 vs. 12.7 by Akinbami
et al. [6]. This marked difference can also be attributed
to female steroid sex hormones. Bonds and Midoro-
Horiuti [34] described estrogens involvement in allergic
sensitization as well as lung function and mechanics,
where for example they can relax airway smooth muscle
and increase ciliary beat frequency. Sex hormones have
been implicated in the interaction and modulation of
TLR expression and function, where lipopolysaccharide-
induced airway inflammation is reduced in female rats
and increased after stimulation with testosterone [35, 36].
Table 7 Logistic Regression Analysis adjusted by gender of the association between TLR4, TLR2 and CD14 SNPs and asthma
Males Females
Adjusted OR 95 % CI P-value Adjusted OR 95 % CI P-value
TLR4 +896
AG 2.25 0.37-13.67 0.378 0.41 0.11-1.51 0.181
TLR4 +1196
CT 3.56 0.50-25.56 0.206 0.48 0.13-1.84 0.286
TLR4 -6687
AG 3.00 0.26-34.57 0.378 1.20 0.39-3.66 0.748
AA 0.33 0.02-7.14 0.482 1.11 0.33-3.75 0.865
TLR2 +596
CT 0.67 0.11-4.17 0.665 6.53 1.82-23.40 0.004
TT 6.04 1.59-23.01 0.008
TLR2 -16934
AT 2.40 0.85-6.73 0.096
AA 0.13 0.02-0.90 0.039 0.90 0.27-3.00 0.864
TLR2 +399
AG 0.60 0.12-2.89 0.525 2.30 0.93-5.67 0.070
GG 0.74 0.18-3.05 0.678
TLR2 +1349
CT 2.47 0.47-12.95 0.286
CD14 -159
AG 1.94 0.29-13.19 0.496 0.73 0.29-1.85 0.503
AA 2.79 0.36-21.73 0.325 1.00 0.28-3.54 1
CD14 +1188
CG 0.72 0.28-1.90 0.513
Legend: OR odds ratio, CI confidence interval
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Other study has shown inhibition of TLR agonist-induced
interleukin (IL-8) release by estradiol in cystic fibrosis
bronchial epithelial cells [37].
The TLR2 +596 SNP is characterized as a synonymous
or silent mutation (sSNP) whose functional mechanism
is unknown. The concept of this type of SNPs of being
“silent” is questionable since in some cases these mutations
are responsible of more profound effects than non-
synonymous SNPs and their importance relies on the com-
parable occurrence 1.1 % vs. 1.5 % for non-synonymous in
coding regions [38]. Based on studies of other sSNPs it
could create a translational pause or affect protein folding,
mRNA splicing, mRNA structure and stability, protein
abundance, microRNAs binding sites, co-translational
protein folding and post-translational modifications via
mRNA-RNA and mRNA protein interactions [38–42].
Speculations exist about how the +596 SNP could
lower TLR2 expression in innate immune cell mem-
branes [18, 43]. It has been hypothesized that this sSNP
can alter function of the integrin β3 (ITGB3)-TLR2
complex, increasing mold sensitization; decrease cyto-
kine production (TNF-α) in monocytes (CC genotype);
increase (decrease in haplotype with other variants)
TNF-α, IL-10 and IL-8 in peripheral blood leukocytes
(T allele) stimulated with bacterial lipoprotein [43–45].
Finally, it has been suggested that TLR2 SNPs in its
heterodimeric network is a major factor mediating
inter-individual variation in in vitro cytokine responses
to lipopeptide, Pam3CSK4 [33, 46].
The TLR2 SNP, +399A/G and TLR2 -16934 SNP (in
males) also presented an interaction with asthma, but it
was not considered important since the previous analysis
did not reveal any significant associations. In support of
this result, this SNP has not been associated with child-
hood asthma [47].
Our results for the TLR2, TLR4 and CD14 SNPs fre-
quencies are similar to those that have been reported for
Hispanic and Caucasian populations found in the Na-
tional Center for Biotechnology Information (NCBI)
SNP database (details about the comparison of the allele
frequencies in the present Puerto Rican population with
other racial groups included in Additional file 1: Table
S1). Compared to Hispanics as a group, the +596 SNP
presented more heterozygotes and TT homozygotes; but
compared to Caucasians the frequency of TT was the
same. Surprisingly, the TLR4 +1196 SNP frequencies ob-
tained for the studied population are exactly the same as
that found in Mexicans even though these two Hispanic
groups present asthma disparities in terms of asthma
prevalence, Puerto Ricans presenting the highest and
Mexicans the lowest compared to non-Hispanic whites
and blacks [4, 6]. The AA genotype of the TLR2 -16934
SNP was more representative in Puerto Ricans as com-
pared to Caucasians and Hispanics. Frequencies for the
TLR4 +896 and TLR2 +1349 SNP genotypes in Puerto
Ricans are very similar to African Americans. Genotype
frequencies for TLR4 +896, TLR2 +1349 and CD14 +1188
variants were somewhat similar to those reported for the
African population. Frequencies for the CD14 SNP in
asthmatics (AA = 0.32, AG = 0.47, GG= 0.21) relate well
with that previously reported by Choudry, et al. [21]
(0.29, 0.50 and 0.21, respectively). A significant associ-
ation to asthma was not encountered possibly due to
age differences between the two designs (childhood
against adulthood). O’Donnell et al. [48] described an
increased OR for atopy and airway hyper-responsiveness
in children carriers of the CD14 -159CC genotype, while
the association was not identified among adults, suggest-
ing an age-dependent modulation of the atopic phenotype.
The analysis of genetic association to complex diseases
(e.g. asthma) often exhibits result inconsistency. In fact,
we found the TLR2 +596 SNP to be associated to asthma
in Puerto Ricans, but others did not obtain any association
with asthma in farmers/non-farmers European children
[22]. Noguchi et al. [49] did not detect association to the
development of asthma and total IgE serum levels in the
presence of the +596 variant but stated that low frequency
of some haplotypes including it as well as +1349 SNP im-
peded the relation to asthma development. These variable
findings may be related to a number of factors which may
represent limitations. Discrepancies in status of the risk/
association of TLR variants in asthma can be explained by
differences in ethnicity or admixture, environmental expo-
sures such as dust allergens and endotoxins and even
gene-gene and gene-environment interactions [50–57].
Low gene penetrance, low allele frequency and linkage dis-
equilibrium are other factors that may avoid interactions
of SNPs with disease [32, 33, 41, 50, 52, 58]. These proper-
ties probably explain why some of the other SNPs with
relatively low MAF evaluated in our study did not result
significant (TLR4 +896 and +1196 SNPs). Although a
sample size calculation was performed, insufficient power
[54, 59] could possibly prevent any link between the other
SNPs and asthma. Replication of the presented genetic
analysis is advised in an effort to account for those limita-
tions and consider other unmeasured confounding factors.
Genetic variation in genes responsible for ENX recog-
nition (TLRs) could modify their respective signaling
pathway. Asthma susceptibility caused by this variation
could be developed as an increase or reduction in NF-kB
signaling that ultimately leads to an increase or reduc-
tion in the production of the pro-inflammatory media-
tors such as cytokines: interleukins IL-6 and IL-8. The
expression of genetic variants can be modified by envir-
onmental effects of pollution, allergen exposure, social
stressors and other conditions [60]. Interests in this aspect
are seen in studies from Kerkhof et al. [61] where TLR2
-16934 (rs4696480) was shown to modify the effect of
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PM2.5 exposure (traffic-related) on doctor-diagnosed
asthma prevalence in the age range of birth to 8 years
in a population from Netherlands. The TLR2 +596 SNP
was also evaluated too but did not interact with particle
pollution. Nonetheless, increasing the sample size of
the present study which is characterized by a different
ethnic population could reveal a different biological
scenario. Further studies are needed to confirm the
functionality of this particular SNP in vitro.
Conclusions
Our study demonstrates an association between the
TLR2 +596 SNP and asthma in Puerto Ricans. This variant
is a potential gene-environment interaction candidate that
may be able to modify the biological effects generated by
exposure to environmental endotoxins in particle pollution,
which are known to exacerbate asthmatic symptoms,
and in that way modulate negative or positively the
pro-inflammatory response in asthmatic individuals. Over-
all, the study represents a step forward not only in search-
ing causes to explain the characteristic high prevalence of
asthma in the Puerto Rican population, but also in identi-
fying SNPs that could be considered as targets for the ad-
vancement of the pharmacogenomics field. In the future,
it will help in the improvement of current asthma therapy
and will provide the basis for the effectiveness of personal-
ized medicine in Puerto Rican asthmatics.
Additional file
Additional file 1: Table S1. Comparison of TLR2, TLR4 and CD14 SNP
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African = HapMap YRI). The NCBI database was used as a source for those
frequencies and ancestral alleles are highlighted. (DOC 59 kb)
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